Curanex Pharmaceuticals Common Stock

CURX | NASDAQ

$5.29

+$0.35 (+7.09%)

At close: Oct 30, 2026, 3:59 PM ET

$5.10

-$0.19 (-3.63%)

Pre-market: Nov 2, 2026, 4:00 AM ET

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022
PE Ratio	-2.22	-309.23	-5.83K	-5.51K
PEG Ratio	0	-0.17	1.06K	n/a
PS Ratio	n/a	n/a	n/a	4.29K
PB Ratio	0.83	221.62	1.86K	n/a
P/FCF Ratio	-0.89	-200.79	-929.63K	n/a
P/OCF Ratio	-0.89	-200.79	-929.63K	n/a
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.03	n/a	n/a	n/a
Quick Ratio	81.93	35.54	5.21	n/a
Current Ratio	81.93	35.54	5.21	n/a
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	-496.55	n/a	n/a	n/a
Return on Equity	-37.66%	-71.82%	-31.95%	n/a
Return on Assets	-36.49%	-69.80%	-25.82%	n/a
Return on Invested Capital	-36.65%	-72.53%	-32.12%	n/a
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	17.03%
Net Profit Margin	n/a	n/a	n/a	-77.82%
Pretax Profit Margin	n/a	n/a	n/a	-77.82%
Operating Profit Margin	n/a	n/a	n/a	-77.82%
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	3.56%